Current Report Filing (8-k)
October 19 2016 - 7:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8K
CURRENT REPORT
Pursuant to Section 13 OR 15 (d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
October 19, 2016
ZYNERBA PHARMACEUTICALS, INC.
(Exact Name of Issuer as Specified in Charter)
Delaware
|
|
001-37526
|
|
26-0389433
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
80 W. Lancaster Avenue, Suite 300
Devon, PA 19333
|
|
(Address of Principal Executive Offices)
|
|
(484) 581-7505
(Registrants Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a12 under the Exchange Act (17 CFR 240.14a12)
|
o
|
Precommencement communications pursuant to Rule 14d2(b) under the Exchange Act (17 CFR 240.14d2(b))
|
o
|
Precommencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e4(c))
|
Item 8.01 Other Events
Attached as Exhibit 99.1 is a presentation that Zynerba Pharmaceuticals, Inc. will post on its website on October 19, 2016 and may use from time to time in presentations or discussions with investors, analysts and other parties.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No.
|
|
Document
|
|
|
|
99.1
|
|
Zynerba Pharmaceuticals, Inc. Presentation.
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 19, 2016
|
|
|
ZYNERBA PHARMACEUTICALS, INC.
|
|
|
|
|
By:
|
/s/ Suzanne Hanlon
|
|
|
Name: Suzanne Hanlon
|
|
|
Title: Secretary, General Counsel and Vice President, Human Resources
|
3
EXHIBIT INDEX
Exhibit
No.
|
|
Document
|
|
|
|
99.1
|
|
Zynerba Pharmaceuticals, Inc. Presentation.
|
4
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Sep 2023 to Sep 2024